Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse

Abstract Background Migraine is a disabling neurologic disease that can fluctuate over time in severity, frequency, and acute medication use. Harris Poll Migraine Report Card was a US population-based survey to ascertain quantifiable distinctions amongst individuals with current versus previous high...

Full description

Bibliographic Details
Main Authors: Amaal J. Starling, Roger Cady, Dawn C. Buse, Meghan Buzby, Charlie Spinale, Kathy Steinberg, Kevin Lenaburg, Steven Kymes
Format: Article
Language:English
Published: BMC 2024-02-01
Series:The Journal of Headache and Pain
Subjects:
Online Access:https://doi.org/10.1186/s10194-024-01725-2
_version_ 1797273855227592704
author Amaal J. Starling
Roger Cady
Dawn C. Buse
Meghan Buzby
Charlie Spinale
Kathy Steinberg
Kevin Lenaburg
Steven Kymes
author_facet Amaal J. Starling
Roger Cady
Dawn C. Buse
Meghan Buzby
Charlie Spinale
Kathy Steinberg
Kevin Lenaburg
Steven Kymes
author_sort Amaal J. Starling
collection DOAJ
description Abstract Background Migraine is a disabling neurologic disease that can fluctuate over time in severity, frequency, and acute medication use. Harris Poll Migraine Report Card was a US population-based survey to ascertain quantifiable distinctions amongst individuals with current versus previous high-frequency headache/migraine and acute medication overuse (HFM+AMO). The objective of this report is to compare self-reported experiences in the migraine journey of adults with HFM+AMO to those who previously experienced HFM+AMO but currently have a sustained reduction in headache/migraine frequency and acute medication use. Methods An online survey was available to a general population panel of adults (≥18 years) with migraine per the ID Migraine™ screener. Respondents were classified into “current HFM+AMO” (within the last few months had ≥8 headache days/month and ≥10 days/month of acute medication use; n=440) or “previous HFM+AMO” (previously had HFM+AMO, but within the last few months had ≤7 headache days/month and ≤9 days/month of acute medication use; n=110). Survey questions pertained to demographics, diagnosis, living with migraine, healthcare provider (HCP) communication, and treatment. Results Participants in the current HFM+AMO group had 15.2 monthly headache days and 17.4 days of monthly acute medication use in last few months compared to 4.2 and 4.1 days for the previous HFM+AMO group, respectively. Overall, current preventive pharmacologic treatment use was low (15-16%; P>0.1 for current vs previous) in both groups. Previous HFM+AMO respondents reported better current acute treatment optimization. More respondents with current (80%) than previous HFM+AMO (66%) expressed concern with their current health (P<0.05). More than one-third of both groups wished their HCP better understood their mental/emotional health (current 37%, previous 35%; P>0.1 for current vs previous) and 47% (current) to 54% (previous) of respondents worried about asking their HCP too many questions (P>0.1 for current vs previous). Conclusion Apart from optimization of acute medication, medical interventions did not significantly differentiate between the current and previous HFM+AMO groups. Use of preventive pharmacological medication was low in both groups. Adults with current HFM+AMO more often had health concerns, yet both groups expressed concerns of disease burden. Optimization of acute and preventive medication and addressing mental/emotional health concerns of patients are areas where migraine care may impact outcomes regardless of their disease burden. Graphical Abstract
first_indexed 2024-03-07T14:50:07Z
format Article
id doaj.art-f6d2ea6da8204c00ab109e81db1a5cfb
institution Directory Open Access Journal
issn 1129-2377
language English
last_indexed 2024-03-07T14:50:07Z
publishDate 2024-02-01
publisher BMC
record_format Article
series The Journal of Headache and Pain
spelling doaj.art-f6d2ea6da8204c00ab109e81db1a5cfb2024-03-05T19:47:58ZengBMCThe Journal of Headache and Pain1129-23772024-02-0125111410.1186/s10194-024-01725-2Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuseAmaal J. Starling0Roger Cady1Dawn C. Buse2Meghan Buzby3Charlie Spinale4Kathy Steinberg5Kevin Lenaburg6Steven Kymes7Mayo ClinicRK ConsultsAlbert Einstein College of MedicineCoalition for Headache and Migraine Patients (CHAMP)The Harris PollThe Harris PollClusterbusters, IncLundbeck LLCAbstract Background Migraine is a disabling neurologic disease that can fluctuate over time in severity, frequency, and acute medication use. Harris Poll Migraine Report Card was a US population-based survey to ascertain quantifiable distinctions amongst individuals with current versus previous high-frequency headache/migraine and acute medication overuse (HFM+AMO). The objective of this report is to compare self-reported experiences in the migraine journey of adults with HFM+AMO to those who previously experienced HFM+AMO but currently have a sustained reduction in headache/migraine frequency and acute medication use. Methods An online survey was available to a general population panel of adults (≥18 years) with migraine per the ID Migraine™ screener. Respondents were classified into “current HFM+AMO” (within the last few months had ≥8 headache days/month and ≥10 days/month of acute medication use; n=440) or “previous HFM+AMO” (previously had HFM+AMO, but within the last few months had ≤7 headache days/month and ≤9 days/month of acute medication use; n=110). Survey questions pertained to demographics, diagnosis, living with migraine, healthcare provider (HCP) communication, and treatment. Results Participants in the current HFM+AMO group had 15.2 monthly headache days and 17.4 days of monthly acute medication use in last few months compared to 4.2 and 4.1 days for the previous HFM+AMO group, respectively. Overall, current preventive pharmacologic treatment use was low (15-16%; P>0.1 for current vs previous) in both groups. Previous HFM+AMO respondents reported better current acute treatment optimization. More respondents with current (80%) than previous HFM+AMO (66%) expressed concern with their current health (P<0.05). More than one-third of both groups wished their HCP better understood their mental/emotional health (current 37%, previous 35%; P>0.1 for current vs previous) and 47% (current) to 54% (previous) of respondents worried about asking their HCP too many questions (P>0.1 for current vs previous). Conclusion Apart from optimization of acute medication, medical interventions did not significantly differentiate between the current and previous HFM+AMO groups. Use of preventive pharmacological medication was low in both groups. Adults with current HFM+AMO more often had health concerns, yet both groups expressed concerns of disease burden. Optimization of acute and preventive medication and addressing mental/emotional health concerns of patients are areas where migraine care may impact outcomes regardless of their disease burden. Graphical Abstracthttps://doi.org/10.1186/s10194-024-01725-2Acute medication overuseHigh-frequency migraineChronic migrainePatient perspectiveHarris PollSurvey
spellingShingle Amaal J. Starling
Roger Cady
Dawn C. Buse
Meghan Buzby
Charlie Spinale
Kathy Steinberg
Kevin Lenaburg
Steven Kymes
Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse
The Journal of Headache and Pain
Acute medication overuse
High-frequency migraine
Chronic migraine
Patient perspective
Harris Poll
Survey
title Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse
title_full Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse
title_fullStr Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse
title_full_unstemmed Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse
title_short Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse
title_sort harris poll migraine report card population based examination of high frequency headache migraine and acute medication overuse
topic Acute medication overuse
High-frequency migraine
Chronic migraine
Patient perspective
Harris Poll
Survey
url https://doi.org/10.1186/s10194-024-01725-2
work_keys_str_mv AT amaaljstarling harrispollmigrainereportcardpopulationbasedexaminationofhighfrequencyheadachemigraineandacutemedicationoveruse
AT rogercady harrispollmigrainereportcardpopulationbasedexaminationofhighfrequencyheadachemigraineandacutemedicationoveruse
AT dawncbuse harrispollmigrainereportcardpopulationbasedexaminationofhighfrequencyheadachemigraineandacutemedicationoveruse
AT meghanbuzby harrispollmigrainereportcardpopulationbasedexaminationofhighfrequencyheadachemigraineandacutemedicationoveruse
AT charliespinale harrispollmigrainereportcardpopulationbasedexaminationofhighfrequencyheadachemigraineandacutemedicationoveruse
AT kathysteinberg harrispollmigrainereportcardpopulationbasedexaminationofhighfrequencyheadachemigraineandacutemedicationoveruse
AT kevinlenaburg harrispollmigrainereportcardpopulationbasedexaminationofhighfrequencyheadachemigraineandacutemedicationoveruse
AT stevenkymes harrispollmigrainereportcardpopulationbasedexaminationofhighfrequencyheadachemigraineandacutemedicationoveruse